Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer

被引:66
作者
Kirisits, Christian [1 ]
Lang, Stefan [1 ]
Dimopoutos, Johannes [1 ]
Oechs, Karin [1 ]
Georg, Dietmar [1 ]
Poetter, Richard [1 ]
机构
[1] Med Univ Vienna, Dept Radiotherapy & Radiobiol, A-1090 Vienna, Austria
关键词
brachytherapy; cervix cancer; treatment planning; MRI;
D O I
10.1016/j.radonc.2006.10.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
intracavitary applicator insertion and the use of only one MRI treatment plan for cervical cancer brachytherapy. Materials and methods: GTV, high risk (HR) CTV and OAR were delineated and analysed for 14 patients. Data using the individual approach were taken from the actual irradiated plans. The "single plan procedure" was simulated by matching the dose distribution of the first plan to the MRI datasets of each subsequent implantation. Total doses from brachytherapy were added up and normalized to 2 Gy fractionation (EQD2). Results: The mean D90 for HR CTV was 6 Gy higher when using one plan than when using individual treatment plans. The D-2cc increased 3.5 Gy for the bladder, 4.2 Gy for the rectum and 5.8 Gy for the sigmoid. The use of only one treatment plan would have resulted in 2, 1 and 5 extra cases exceeding total D-2cc constraints for bladder (90 Gy), rectum (75 Gy) and sigmoid (75 Gy), respectively. Conclusion: The use of only one treatment plan for several applications results in higher dose to target and OAR structures. CT, clinical examination and X-ray findings can help to reduce certain situations of overdosage, when individual MRI based treatment planning is not available for each fraction. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 19 条
[1]  
[Anonymous], 1985, 38 ICRU
[2]  
Bahena JH, 1998, INT J RADIAT ONCOL, V41, P13
[3]   Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38 [J].
Datta, NR ;
Kumar, S ;
Das, KJM ;
Pandey, CM ;
Halder, S ;
Ayyagari, S .
RADIOTHERAPY AND ONCOLOGY, 2001, 60 (01) :15-24
[4]  
Dimopoulos J, 2004, RADIOTHER ONCOL, V71, pS10
[5]  
Erickson B, 2004, RADIOTHER ONCOL, V71, pS9
[6]   ANATOMIC VARIATION OF GYNECOLOGIC BRACHYTHERAPY PRESCRIPTION POINTS [J].
GRIGSBY, PW ;
GEORGIOU, A ;
WILLIAMSON, JF ;
PEREZ, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03) :725-729
[7]   Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV [J].
Haie-Meder, C ;
Pötter, R ;
Van Limbergen, E ;
Briot, E ;
De Brabandere, M ;
Dimopoulos, J ;
Dumas, I ;
Hellebust, TP ;
Kirisits, C ;
Lang, SF ;
Muschitz, S ;
Nevinson, J ;
Nulens, A ;
Petrow, P ;
Wachter-Gerstner, N .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :235-245
[8]   Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations [J].
Hellebust, TP ;
Dale, E ;
Skjonsberg, A ;
Olsen, DR .
RADIOTHERAPY AND ONCOLOGY, 2001, 60 (03) :273-280
[9]   Changes in applicator position with fractionated high dose rate gynaecological brachytherapy [J].
Hoskin, PJ ;
Cook, M ;
Bouscale, D ;
Cansdale, J .
RADIOTHERAPY AND ONCOLOGY, 1996, 40 (01) :59-62
[10]  
Joiner MC., 2002, BASIC CLIN RADIOBIOL, P120